formoterol
Formoterol is a long-acting beta-2 agonist bronchodilator. Inhaled twice daily, it relaxes the muscle around the airways and keeps them open, helping maintain breathing in chronic obstructive pulmonary disease.
This page is based on FDA prescribing information and Health Canada product information for formoterol; the mechanism is explained in plain language, and analogies are used only where they stay accurate.
How it works
Explains what the medicine does in the body, not dosing, side effects, or safety.
An analogy
Tight airways are like pinched garden hoses that let little air through. Formoterol is a slow-acting release clip: it settles onto beta-2 receptors in the airway wall and gently relaxes the muscle for about twelve hours, so the hose stays open and breathing stays easy through the day and night.
In simple terms
In COPD the airways are narrowed, making breathing hard. Formoterol is an inhaled medicine that stimulates beta-2 receptors on the smooth muscle surrounding the airways. The muscle relaxes, the airways widen, and airflow improves. Because its effect lasts around twelve hours, it is used twice daily as a maintenance treatment, not for sudden symptom relief.
In depth
Formoterol fumarate is a long-acting, selective beta-2 adrenergic agonist with a rapid onset comparable to salbutamol but a duration of about twelve hours. Receptor activation stimulates adenylyl cyclase, raising intracellular cAMP and relaxing airway smooth muscle; it also inhibits mast cell mediator release. Regular use maintains bronchodilation in COPD.
See it in motion
A schematic animation of the mechanism — simplified for clarity, not drawn to scale.
How formoterol keeps COPD airways open as a long-acting beta-2 agonist
- Formoterol is a slow-acting release clip: it settles onto beta-2 receptors in the airway wall and gently relaxes the muscle for about twelve hours, so the hose stays open and breathing stays easy through the day and night.
- Formoterol fumarate is a long-acting, selective beta-2 adrenergic agonist with a rapid onset comparable to salbutamol but a duration of about twelve hours.
- Receptor activation stimulates adenylyl cyclase, raising intracellular cAMP and relaxing airway smooth muscle; it also inhibits mast cell mediator release.
- Regular use maintains bronchodilation in COPD.
Target: Beta-2 adrenergic receptor
A receptor on airway smooth muscle that, when stimulated, relaxes the muscle and opens the airways; long-acting stimulation keeps bronchi widened through day and night.
Approved uses
Approved uses differ by country and change over time. Always follow your local prescribing information.
Approved uses in United States
FDA- Long-term, twice daily maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema
- Formoterol fumarate inhalation solution is not indicated to treat acute deteriorations of chronic obstructive pulmonary disease
Official sources
The statements on this page trace back to these records.
- U.S. Food and Drug Administration: formoterol fumarate prescribing information
U.S. Food and Drug Administration
This page explains how the medicine works — it isn’t the patient leaflet. For anything that applies to you, read the leaflet that came with your medicine or ask your pharmacist.
MedUnfold provides educational content and is not medical advice. Always follow your local prescribing information and healthcare professional.